Evaluation of melatonin effect on breast cancer
Phase 3
- Conditions
- Breast cancer.Malignant neoplasm of breast
- Registration Number
- IRCT20171105037262N5
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Having breast cancer at any stage undergoing neoadjuvant chemotherapy
Above 25 years of age
Exclusion Criteria
Having renal and liver failure
Abnormal blood test
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor grade. Timepoint: At the beginning and end of intervention. Method of measurement: Microscopic.
- Secondary Outcome Measures
Name Time Method Serum levels of biomarkers related to inflammation and oxidative stress. Timepoint: At the beginning and end of interventio. Method of measurement: ELISA.